Emphasys Med Files for IPO

Emphasys Medical Inc., a Redwood City, Calif.-based medical device company focused on emphysema, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol EMPH, with Morgan Stanley serving as lead underwriter. The company has raised around $80 million in VC funding since 2000, from firms like Advanced Technology Ventures (17.8%), Morgenthaler Ventures (13.8%), St. Paul Venture Capital (11.5%) OrbiMed Advisors (13.7%), ABS Ventures (10%), Morgan Stanley Venture Partners (7.4%), Cargill Ventures (6.1%) and Neww Enterprise Associates. www.emphasysmedical.com